TribLIVE

| Business


 
Larger text Larger text Smaller text Smaller text | Order Photo Reprints

Complexa raises $13M to fund trials of kidney disease drug

On the Grid

From the shale fields to the cooling towers, Trib Total Media covers the energy industry in Western Pennsylvania and beyond. For the latest news and views on gas, coal, electricity and more, check out On the Grid today.

Wednesday, June 4, 2014, 10:51 a.m.
 

Complexa Inc., a South Side-based drug development company, said it raised $13 million from investors that will fund clinical trials of a drug to treat kidney disease.

The funding round, Complexa's second, was led by Jafco Life Science Investment, an arm of Japanese private equity firm Jafco Co. Ltd.

The company previously raised more than $8 million from venture capital investors to license and develop molecules discovered and patented by professor Bruce Freeman and a team of researchers at the University of Pittsburgh.

There is “great interest” in Complexa's work from large pharmaceutical companies, Jafco officials said in a statement.

Add Alex Nixon to your Google+ circles.

 

 

 
 


Show commenting policy

Most-Read Business Headlines

  1. OPEC decision on crude sets small producers on perilous path, analysts say
  2. Energy stocks ‘hammered’ as crude oil tumbles
  3. Mirai debut brings  fuel cell future closer
  4. Jaguar coupe can outstyle convertible
  5. Modified van misfires
  6. Earlier openings make Black Friday shopping easier for bargain-hunters
  7. October mine inspections result in 127 citations
  8. Committee looks into beneficial uses of coal ash
  9. Florida roommates find a career in playing video games on web channel Twitch
  10. Retailers court web customers with free shipping
  11. Company seeks to reopen coal mine in Nottingham, Washington County
Subscribe today! Click here for our subscription offers.